Free Trial

Novanta Inc. (NASDAQ:NOVT) Stock Position Raised by Deutsche Bank AG

Novanta logo with Computer and Technology background

Deutsche Bank AG increased its position in Novanta Inc. (NASDAQ:NOVT - Free Report) by 57.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 33,840 shares of the technology company's stock after purchasing an additional 12,350 shares during the period. Deutsche Bank AG owned about 0.09% of Novanta worth $5,170,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in NOVT. BW Gestao de Investimentos Ltda. purchased a new stake in shares of Novanta in the fourth quarter valued at $2,317,000. Balyasny Asset Management L.P. acquired a new position in Novanta during the fourth quarter valued at $733,000. Ameriprise Financial Inc. lifted its stake in Novanta by 9.9% in the 4th quarter. Ameriprise Financial Inc. now owns 457,225 shares of the technology company's stock worth $69,850,000 after acquiring an additional 41,024 shares in the last quarter. Northern Trust Corp boosted its position in Novanta by 14.0% during the 4th quarter. Northern Trust Corp now owns 487,688 shares of the technology company's stock worth $74,504,000 after acquiring an additional 59,986 shares during the period. Finally, Johnson Financial Group Inc. boosted its position in Novanta by 482.1% during the 4th quarter. Johnson Financial Group Inc. now owns 326 shares of the technology company's stock worth $49,000 after acquiring an additional 270 shares during the period. 98.35% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Separately, Robert W. Baird dropped their target price on Novanta from $169.00 to $160.00 and set a "neutral" rating on the stock in a report on Monday, March 3rd.

Get Our Latest Analysis on Novanta

Novanta Stock Up 1.2%

Novanta stock opened at $131.17 on Monday. Novanta Inc. has a twelve month low of $98.76 and a twelve month high of $187.12. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.81 and a current ratio of 2.79. The firm has a market cap of $4.72 billion, a PE ratio of 78.55 and a beta of 1.51. The firm's 50 day moving average price is $122.70 and its two-hundred day moving average price is $144.34.

Novanta (NASDAQ:NOVT - Get Free Report) last posted its quarterly earnings results on Tuesday, May 6th. The technology company reported $0.74 earnings per share for the quarter, topping analysts' consensus estimates of $0.68 by $0.06. Novanta had a net margin of 6.52% and a return on equity of 15.20%. The business had revenue of $233.37 million for the quarter, compared to the consensus estimate of $233.34 million. During the same period in the prior year, the business posted $0.74 earnings per share. Novanta's revenue for the quarter was up 1.1% compared to the same quarter last year. On average, research analysts predict that Novanta Inc. will post 3.03 EPS for the current fiscal year.

Novanta Company Profile

(Free Report)

Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.

Recommended Stories

Institutional Ownership by Quarter for Novanta (NASDAQ:NOVT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Novanta Right Now?

Before you consider Novanta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novanta wasn't on the list.

While Novanta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines